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Dicer is essential for plant, Caenorhabditis ele-
gans, and Drosophila antiviral responses be-
cause of its role in generating small interfering
RNA (siRNA) from viral genomes. We show
that because of impaired miRNA production,
mice with a variant Dicer1 allele (Dicer1d/d)
were more susceptible to vesicular stomatitis
virus (VSV) infection. We did not detect VSV
genome-derived siRNA in wild-type cells or
any alteration of interferon-mediated antiviral
responses by Dicer1 deficiency. Rather, we
found that host miR24 and miR93 could target
viral large protein (L protein) and phosphopro-
tein (P protein) genes, and a lack of miR24 and
miR93 was responsible for increased VSV repli-
cation in Dicer1d/d cells. Our data suggest that
host miRNA can play a role in host interactions
with viruses.
INTRODUCTION
Dicer is an RNase III enzyme required for processing small
regulatory RNA, including small interfering RNA (siRNA)
and microRNA (miRNA), which respectively originate
from exogenous long double-stranded RNA and endoge-
nous single-stranded hairpin- or repeat-associated pre-
cursors (Hannon, 2002; Carmell and Hannon, 2004; Bartel,
2004). siRNA functions by means of perfect or near-
perfect base pairing with mRNA targets, subsequently
guiding mRNA degradation. miRNA mostly regulates
gene expression by imperfect base pairing with target
mRNA, subsequently guiding mRNA cleavage or transla-
tional repression (Bartel, 2004; Meister and Tuschl,
2004; Jing et al., 2005). Although RNA interference(RNAi) is an evolutionarily conserved process, there is
remarkable cross-species diversity in the function and
number of Dicer-like molecules (Xie et al., 2004; Lee
et al., 2004). The Arabidopsis genome encodes four
Dicer-like (Dcl) proteins. Dcl-1 is required for miRNA
production and plant development (Park et al., 2002).
Dcl-2 is important for viral siRNA biogenesis and antiviral
defense. Dcl-3 is required for generating endogenous
siRNA (Xie et al., 2004). Dcl-4 is required for transacting
siRNA biogenesis (Xie et al., 2005) and for Dcl-2 antiviral
function (Deleris et al., 2006). The Drosophila genome
contains two genes encoding proteins of the Dicer family.
Dcr-1 is required for pre-miRNA processing and RNAi,
whereas Dcr-2 is involved in siRNA generation (Lee
et al., 2004). Caenorhabditis elegans (C. elegans) has
one Dicer responsible for the processing of both siRNA
and miRNA (Grishok et al., 2001). There is a single Dicer
gene in mammals, and this gene presumably mediates
the processing of all miRNA (Bartel, 2004).
Mutant Dicer1 alleles have been generated in mice and
show that Dicer1 functions in the development of multiple
tissues. An allele created by replacing exon 24 of Dicer1
with a neomycin-resistance (neor) cassette abolished
Dicer1 activity and caused embryonic lethality with
a loss of pluripotent stem cells (Bernstein et al., 2003).
Mice with a deletion of exon 1 and 2 of the Dicer1 gene
were also embryonically lethal with impaired angiogenesis
(Yang et al., 2005). Tissue-specific inactivation of Dicer in
the mouse limb bud mesenchyme, lung epithelium, skin
progenitor cells, and T cell lineage led to the conclusion
that Dicer is essential for proper limb skeletal elements,
lung morphogenesis, skin morphogenesis, and T cell
development and differentiation, respectively (Yi et al.,
2006; Harris et al., 2006; Harfe et al., 2005; Andl et al.,
2006; Muljo et al., 2005; Cobb et al., 2005; Cobb
et al., 2006).
In plants, worms, and insects, Dicer processes dou-
ble-stranded viral RNA into siRNA, and these siRNAsImmunity 27, 123–134, July 2007 ª2007 Elsevier Inc. 123
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Hypersusceptibility to VSV in Dicer-Deficient MiceFigure 1. Generation of Dicer1-Deficient
Mice
(A) The gene-trap-vector insertion site in the
Dicer1 gene. b-geo stands for the b-galctosi-
dase-neomycin resistance fusion gene. Arrows
denote PCR primers for genotyping.
(B) PCR genotyping of representative litters
containing wild-type (+/+), heterozygous (+/d),
and homozygous (d/d) mice. Common sense
primer (P1) in intron 24 and antisense primers
(P2/P3) within exon 25 and the retrovirus
vector, respectively, were used to amplify the
wild-type (802 bp) and mutant (547 bp) alleles.
(C) The amount of wild-type Dicer1 mRNA in
whole embryos at embryonic day 9.5 from the
survival line and the embryonically lethal line.
Real-time PCR detecting only the wild-type
Dicer1 mRNA was performed with total RNA
extracted from whole embryos. The relative
RNA amounts were calculated and normalized
with internal control GAPDH. The mean amount
from the wild-type embryos was adjusted to
one. Error bars show the variance of each
group.
(D) Dicer1-protein expression was analyzed by
immunoblotting cell lysates from mouse
peritoneal macrophages. b-actin was used as
a loading control. The asterisk stands for a non-
specific band.
(E) Dicer1-protein expression in various tissues
from wild-type and Dicer1d/d mice was ana-
lyzed by immunoblotting. b-actin was used as
a loading control. 293T cell lysate was included
in the experiment.
(F) RNA analysis of miRNA expression in mouse
peritoneal macrophages. A total of 20 mg of
enriched small RNA was separated by a 15%
TBE-urea gel and transferred to nylon
membranes. Blots were probed for let-7a and
miR-16 and visualized by autoradiography.
Ethidium-bromide staining of 5S ribosomal RNA (rRNA) served as loading controls (bottom). The arrows indicate processed mature miRNA and
pre-miRNA. A radiolabeled Decade marker, consisting of 20, 30, 40, 50, 60, 70, and 80 nucleotide-size marker, was used (not shown). A representative
result is shown out of three independent experiments.in turn inhibit viral replication (Voinnet, 2005; Wang et al.,
2006; Galiana-Arnoux et al., 2006; Wilkins et al., 2005).
However, siRNAs derived from viral genomes have not
been reported in mammals. Interestingly, human miR32
was reported to limit the retrovirus primate foamy virus
type 1 (PFV-1) replication (Lecellier et al., 2005), whereas
a liver-specific miR122 was found to be a positive regu-
lator of hepatitis C virus (HCV) replication (Jopling et al.,
2005). In addition, some mammalian viruses encode
miRNAs themselves (Pfeffer et al., 2005), suggesting
a possible role for the miRNA system in the viral life
cycle. Two recent studies have shown an essential role
for Dicer-2 in host defense against viruses in Drosophila
(Wang et al., 2006; Galiana-Arnoux et al., 2006), but the
role of Dicer1 in the host defense system of mammals
has not been determined. Here, we report the generation
of live adult Dicer1-deficient mice and the evaluation of
the effect of Dicer1 deficiency on viral susceptibility in
vitro and in vivo. Dicer1 deficiency affects viral infections124 Immunity 27, 123–134, July 2007 ª2007 Elsevier Inc.differently depending on the type of virus. Dicer1-
deficient mice and macrophages are hypersusceptible
to infection by vesicular stomatitis virus (VSV), a negative
RNA virus. We demonstrate that cellular miR24 and
miR93 are essential in limiting VSV replication in mice.
RESULTS
Generation of Dicer1-Deficient Mice
We obtained Dicer1-deficient mice by using a gene-trap
method. Heterozygous Dicer1-deficient mice on a mixed
C57BL/6x129 background were generated from 129p2/
Ola ES cells containing a retroviral gene trap in the Dicer1
locus within the 97 base pairs upstream of exon 25
(Figure 1A; the junction sequence is shown in Figure S1
in the Supplemental Data available online). The insertion
led to the expression of a Dicer1-b-galactosidase-neomy-
cin (b-geo) fusion molecule lacking the second RNase III
domain and double-stranded RNA-binding domain
Immunity
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Dicer1’s activity (Bernstein et al., 2003), so mice homozy-
gous for this mutation can be considered to be null with
respect to Dicer1 activity. The genotype of these Dicer1-
deficient mice was determined by PCR with primers
located at each side of the gene trap and in the b-geo cas-
sette (Figures 1A and 1B). As reported by others (Yang
et al., 2005), most homozygotes for this variant Dicer1
allele died in utero with defects in angiogenesis. Unex-
pectedly, we obtained one male live Dicer1-deficient
homozygote after screening approximately 100 litters.
This Dicer1d/d mouse appeared to be healthy, and by
breeding it with other heterozygous mice, we produced
more viable Dicer1d/d mice. Sibling-pair breeding was
conducted for more than ten generations, and a Dicer1-
deficient line was established.
To address why a small fraction of Dicer1d/d mice
escaped embryonic lethality, we examined whether
Dicer1d/d mice produced a trace of wild-type Dicer1. For
this, amounts of wild-type Dicer1 mRNA in whole embryos
(E 9.5) from viable and embryonically lethal lines were
determined by real-time PCR. Embryos from viable
Dicer1d/d lines exhibited greater relative abundance of
wild-type Dicer1 mRNA compared to embryos from the
embryonically lethal lines (Figure 1C). Therefore, it is pos-
sible that there is a threshold amount of Dicer1 expression
that is required for mice to bypass the embryonic lethality,
or it might be that Dicer1 is required in certain tissues for
viability and our Dicer1d/d mice had trace amounts of
Dicer1 expression in those tissues. The expression of
Dicer1 in Dicer1d/d mice is most likely to be caused by
a low-frequency alternative splicing event that removes
the gene-trap-vector sequence, resulting in a wild-type-
processed transcript (Stanford et al., 2001). We found
that the amounts of Dicer1 protein were below detection
in peritoneal macrophages obtained from Dicer1d/d mice
(Figure 1D), but we could detect small amounts of Dicer1
protein in some tissues of Dicer1d/d mice (Figure 1E). It
appears that we have obtained a mouse mutant with
hypomorphic Dicer1 expression. To confirm a functional
deficiency in Dicer1d/d mice, we analyzed peritoneal mac-
rophages isolated from Dicer1d/d mice and found there to
be an impaired processing of the pre-miRNA transcripts
into mature miRNA (Figure 1F).
The unexpected stability of the viable phenotype could
be due to a particular constellation of 129 and C57BL/6
background genes, to an unknown mutation that permits
adequate alternative splicing of the variant Dicer1 tran-
script, or to the elimination of a lethal mutation in relatively
tight linkage with the gene-trap allele through crossing
over. To obtain more information on the genetic back-
ground of the mice, we examined ten wild-type and ten
Dicer1d/d mice with 55 microsatellite markers across the
genome. Although the genome has not been completely
fixed after more than ten generations of sibling breeding,
the 129 and BC57BL/6 strain sequence detected by the
microsatellite markers were similarly distributed in wild-
type and Dicer1d/d mice without substantial deviation
(Table S1).Dicer1 Deficiency Leads to a Hypersusceptibility
to Some Viruses, Such as VSV
The key role played by Dicer1 enzymes in the restriction of
viral proliferation in plants, Drosophila, and C. elegans led
us to examine the effect of mammalian Dicer1 on viral
growth. For this, we determined titers of VSV, encephalo-
myocarditis virus (EMCV), lymphocytic choriomemingitis
virus (LCMV), Coxsackievirus group B serotype 3
(CVB3), Influenza A virus (Flu), Herpes simplex virus type
1 (HSV-1), and vaccinia virus (VV) in infected peritoneal
macrophages isolated from wild-type and Dicer1d/d mice
(Figure 2A). VSV and HSV-1 produced greater amounts
of titers in Dicer1d/d macrophages, whereas the other
viruses tested produced either similar titers or, in some
cases, exhibited a tendency to produce less progeny in
Dicer1d/d macrophages (LCMV). The increase in VSV
production in Dicer1d/d cells appears to be only moderate
but is nevertheless similar to the amount of increases in
viral propagation observed in C. elegans when the siRNA
pathway is impaired (Schott et al., 2005; Wilkins et al.,
2005). It is possible that such a moderate change within
the host is sufficient to tip over the balance between
host and virus, thereby leading to different infection
outcomes. We therefore used VSV to address whether
a Dicer1-deficiency-mediated increase in VSV replication
occurs in mice and to determine what the consequence of
this increase is. We infected Dicer1d/d mice and age- and
sex-matched wild-type control mice with VSV intranasally.
Dicer1d/d mice exhibited reduced survival rates (Figure 2B)
with more severe cases of interstitial pneumonitis with
thickening of the alveolar walls (Figure 2C), accompanied
with denser staining for viral proteins, indicating more
vigorous viral replication (Figure 2D). Likewise, VSV titers
in the brain were approximately 100-fold greater in
Dicer1d/d than in wild-type mice (Figure 2E).
To analyze the Dicer1-deficiency-mediated increase in
VSV permissibility, we used VSV to infect primary macro-
phages isolated from wild-type and Dicer1d/d mice at
m.o.i. (multiplicity of infection) values ranging from 0.1–
100. Compared to the wild-type, Dicer1d/d macrophages
produced higher virus titers (Figure 3A) and had
increased VSV-induced cytopathic effects (Figure 3B).
We monitored viral protein accumulation in wild-type
and Dicer1d/d macrophages after VSV inoculation
(m.o.i. = 10). Dicer1d/d macrophages accumulated
greater amounts of VSV proteins than in wild-type
macrophages (Figure 3C). We measured VSV RNA
accumulation by [3H] metabolic labeling under conditions
in which host mRNA synthesis was inhibited by actino-
mycin D. VSV RNA accumulation was enhanced in
Dicer1d/d compared to wild-type macrophages (Fig-
ure 3D). We also examined the cell internalization of
VSV by determining the amount of trypsin-resistant
VSV associated with cells 1 hr after virus inoculation
(Belkowski and Sen, 1987). Dicer1d/d and wild-type mac-
rophages exhibited similar amounts of internalized VSV
(Figure 3E). Therefore, differences between Dicer1d/d
and wild-type cells in their susceptibility to VSV infection
is not determined at the level of cell entry but ratherImmunity 27, 123–134, July 2007 ª2007 Elsevier Inc. 125
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Hypersusceptibility to VSV in Dicer-Deficient MiceFigure 2. Dicer1-Deficient Mice Are More Susceptible to VSV Infection
(A) Peritoneal macrophages (13 105) isolated fromDicer1d/d and wild-type littermates were infected with different viruses, as is indicated. Viral titers in
the macrophage medium were measured 24 hr after infection at m.o.i. 1.0 by the standard plaque assay, except for the influenza virus. The influenza
virus was used at 107 TCID50, and the viral titer was evaluated by the TCID50 analysis. The mean titers of duplicate samples from three independent
experiments are shown. Error bars represent SD. *p; = 0.018 (VSV) and 0.011 (HSV).
(B) Sex- and age-matched Dicer1+/+ (n = 10) and Dicer1d/d mice (n = 10) were infected intranasally with 2 3 107 pfu VSV per mouse. Mice were
monitored daily for 20 days, and animals surviving at the indicated times are plotted versus time. *p; = 0.028 (log-rank test).
(C) Paraffin-embedded lung sections taken from wild-type and Dicer1d/d mice at 6 days after VSV infection were stained with hematoxilin and eosin
and photographed at a 1003 magnification.
(D) Lung sections were stained with VSV antibodies that recognize all VSV proteins, detected with DAB substrate, and photographed at a 1003mag-
nification.
(E) VSV titers from brain tissues were determined at 6 days after infection by a standard plaque assay on L929 cells, and the mean titers of duplicate
samples from three mice are each expressed. Error bars represent SD. *p; = 0.017.by changes in the efficiency of viral RNA or protein pro-
duction, or both, in host cells.
Dicer Influences VSV Replication by a Mechanism
Distinct from RNAi- or Interferon-Mediated
Responses
Increased virus production caused by Dicer1 deficiency
could be a direct effect of there being little or no produc-
tion of virus-derived siRNAs or host miRNAs that target
viral mRNAs, or it could be the result of ineffective pro-
cessing of the viral miRNA(s) required for completing the
virus life cycle. It also could be due to an indirect effect
of low amounts of host miRNA expression that affect a
cellular protein(s) that is involved in viral replication. We
first examined whether siRNA from the VSV genome can126 Immunity 27, 123–134, July 2007 ª2007 Elsevier Inc.be detected in murine macrophages. By using the radiola-
beled VSV N gene as a probe, we did not detect any siRNA
generated from the VSV genome by RNA-blotting analysis
of small RNA-enriched RNA preparations obtained from
VSV-infected wild-type, heterozygous, and homozygous
Dicer1-deficient macrophages (data not shown). We also
did not detect any VSV-derived small RNA species when
we analyzed [3H] metabolically labeled VSV RNA isolated
from wild-type and Dicer1d/d macrophages (Figure 4A).
This result is consistent with the fact that extensive
cDNA-cloning studies of cells infected with many RNA
viruses have failed to identify small RNA from viruses in
human cells (Pfeffer et al., 2005). This is also consistent
with the report that virus-derived small RNA was not
detected after PFV-1 infection in human cells (Lecellier
Immunity
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More VSV Propagation at the Levels of
Viral RNA and Protein Expression
(A) Viral titers in the medium of Dicer1+/+ and
Dicer1d/d macrophages were measured 36 hr
after VSV infection at different m.o.i. Data are
shown as mean ± SD from duplicate samples
of three independent experiments. *p; = 0.01.
**p < 0.01.
(B) The cytolytic effect of VSV was examined in
macrophages from Dicer1+/+, Dicer1+/d, and
Dicer1d/d mice after infection with VSV at differ-
ent m.o.i. values for 48 hr. Data are shown as
mean ± SD from three independent experi-
ments. *p; < 0.01 (d/d versus +/+).
(C) VSV proteins in peritoneal macrophage
cells from Dicer1+/+ and Dicer1d/d mice were
analyzed by immunoblotting with the cell
lysates with VSV antibodies at 0, 6, and 12 hr
after infection (hpi) with m.o.i of 10. The identi-
ties of individual VSV proteins are shown on the
right. b-actin was used as a loading control.
Relative M protein accumulation is shown at
the bottom.
(D) VSV mRNA synthesis was analyzed by
metabolic labeling. Peritoneal macrophages
were infected with VSV at m.o.i. 500. At 2 hr
post infection, actinomycin D (10 mg per ml)
was added for 1 hr, and then 50 mCi each of
[3H] uridine and [3H] adenosine were added
per ml in the presence of actinomycin D. After the indicated hours post infection, total RNA was extracted, analyzed by electrophoresis in acid aga-
rose-urea gels, and visualized by autoradiography. The identities of the individual VSV mRNA species are indicated on the right. vRNA indicates viral
RNA. Ethidium-bromide staining of ribosomal RNA served as loading controls (bottom). Relative P/M RNA accumulation is shown at the bottom.
(E) Cell penetration of VSV. Peritoneal macrophages from Dicer1+/+ and Dicer1d/d mice were infected with VSV at m.o.i 100 for 2 hr in the presence of
cycloheximide (10 mg/ml) to prevent newly synthesized protein. After washing, the cells were incubated with 0.25% trypsin and 0.025% EDTA for
7 min to remove viruses adsorbed to the cell surface. The amount of intracellular VSV proteins was analyzed by immunoblotting with the cell lysates
with VSV antibodies. b-actin was used as a loading control.et al., 2005). However, because siRNAs generated from
the viral genome in Drosophila were only readily detect-
able in r2d2 mutants but not in wild-type flies (Wang
et al., 2006), we cannot exclude the possibility that siRNA
was generated from the VSV genome in murine cells,
albeit below our detection limit. Nevertheless, it can be
concluded that mammalian Dicer1 influences VSV replica-
tion primarily via a different mechanism.
Type I interferons (IFNs), which include members of the
IFN-a and IFN-b gene family, are known to play an essen-
tial role in the innate immune response against virus infec-
tion in mammals (Basler and Garcia-Sastre, 2002). Thus,
the greater viral load in Dicer1d/d cells could be due to
decreased production of IFNs or a decreased responsive-
ness of the cells to IFNs. We found that Dicer1 deficiency
did not alter the accumulation of cytokine mRNA tran-
scripts, including IFN-b early after VSV infection (Fig-
ure 4B), nor did it alter the production of type I IFN proteins
(Figure 4C). To determine whether the IFN response was
affected by Dicer1 deficiency, we measured the DNA-
binding activity of the interferon-stimulated response
element (ISRE) by performing electromobility-shift assays
in VSV-infected wild-type and Dicer1d/d macrophages,
which showed no differences (Figure 4D). Consistent
with this, the induction of IFN-response genes was notaffected by Dicer1 deficiency (Figure 4E). Moreover,
pretreating the cells with IFN-a before infection prevented
the VSV-induced cytopathic effect in wild-type and
Dicer1d/d macrophages (Figure 4F). Therefore, interferon
production and interferon responses did not appear to
be affected by Dicer1 deficiency.
Some Host miRNAs Can Target VSV
Because we did not find evidence for the induction of the
siRNA pathway after VSV infection, nor did we find alter-
ation of IFN responses by Dicer1 deficiency, we decided
to examine whether any cellular miRNA might be involved
in Dicer1-mediated anti-VSV responses. As has been
done by others (Lecellier et al., 2005; Jing et al., 2005),
we constructed reporter plasmids by fusing different
portions of the VSV sequence (labeled as A to J in
Figure 5A) to the 30 untranslated region (UTR) of a lucifer-
ase reporter gene in both positive (+) and negative ()
orientations and then used these reporters to determine
which region yielded mRNA that could be targeted by
miRNA. Because peritoneal macrophages cannot be
transfected with high efficiency, the reporter-gene assays
were performed by transfection of plasmids into RAW
264.7 macrophages. Because the length may influence
the reporter expression, we paid closest attention toImmunity 27, 123–134, July 2007 ª2007 Elsevier Inc. 127
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Detected in Murine Macrophages and
No Defect in Interferon Responses Was
Found in Dicer1-Deficient Cells
(A) Peritoneal macrophages fromDicer1+/+ and
Dicer1d/d mice were infected with VSV at m.o.i
100, and newly synthesized viral mRNA was
metabolically labeled by [3H] uridine and [3H]
adenosine in the presence of actinomycin
D. Eighteen hours after infection, 5 mg small
RNA was extracted, separated through
a 15% TBE-urea polyacrylamide gel, and
visualized by autoradiography. Dicer1+/+cells
without virus infection were used as a control.
The asterisk refers to labeled tRNA. ‘‘M’’
stands for a decade marker. No 3H siRNA
was detected.
(B) Total RNA in peritoneal macrophages from
Dicer1+/+ and Dicer1d/d mice at 0, 2, and 4 hr
post VSV infection (hpi) were analyzed by ribo-
nuclease-protection assay. The protected
RNA was separated and visualized by autora-
diography. L32 and GAPDH were used as
internal control. The probe without RNase
treatment was also applied to identify the
protected bands (not shown). The result is
a representative of three experiments.
(C) Peritoneal macrophages from Dicer1+/+
and Dicer1d/d mice were infected with VSV at
m.o.i 10 for the indicated hours. Type I IFN ac-
tivity in the culture medium was measured by
IFN bioassay. Results are shown as mean ±
SD from three experiments.
(D) Peritoneal macrophages were infected with
VSV at m.o.i for 0, 4, 8, and 16 hr, and nuclear
extracts were subjected to EMSA with ISG15’s
ISRE site as a probe. The arrow indicates the
DNA-binding complex of IFN-stimulated gene
factor-3 (ISGF-3). The nuclear extract from
wild-type cells 16 hr after VSV infection,
preincubated with a 50-fold excess of unlabeled cold probe, was also loaded as a negative control in lane C. The result is a representative of three
experiments.
(E) Peritoneal macrophages from Dicer1+/+ and Dicer1d/d mice were infected with VSV at an m.o.i of 0.1. RNA was extracted at the indicated time
points after infection, and semiquantitative RT-PCR was performed. RNA extracted from macrophages treated with 10 IU/ml IFN b for 16 hr was
used as a positive control.
(F) Peritoneal macrophages from Dicer1+/+ and Dicer1d/d mice were treated with varying amounts of IFN-a for 24 hr and were then infected with
VSV at m.o.i 10. Thirty-six hours after infection, the cytolytic effect was determined with crystal violet. The result is shown as mean ± SD from
three experiments.differences between reporters containing corresponding
positive and negative sequences. The positive-strand
reporters in C, F, and G sets showed more than a 50%
reduction in luciferase activity in comparison with the
negative-strand reporters (Figure 5B), suggesting that ei-
ther the positive strand or mRNA derived from the C, F,
and G regions of VSV are subject to suppression by a cel-
lular mechanism. VSV infection did not change the profiles
of these reporters (Figure S3), supporting the idea that
VSV infection does not produce VSV-derived siRNA to
suppress VSV gene expression.
We used two computational prediction methods, Micro-
Inspector (Rusinov et al., 2005) and DIANA-microT (Kiria-
kidou et al., 2004), to predict whether any known miRNA
could target the positive-strand sequence in the C, F, or128 Immunity 27, 123–134, July 2007 ª2007 Elsevier Inc.G regions of VSV. We obtained a total of 24 candidate
miRNAs (Figure S4). A candidate miRNA responsible for
reduced reporter-gene expression and VSV replication
would need to be expressed in RAW 264.7 cells and
macrophages. We measured the expression of those can-
didate miRNAs by using primer extension. Among 24
miRNA candidates, miR24, miR93, miR146, and miR378
were found to be expressed in RAW 264.7 cells and in
mouse peritoneal macrophages (Figure 5C). As expected,
these miRNAs were not detected in Dicer1d/d macro-
phages (Figure 5C). The putative miR24-targeted
sequence is located in the region of overlap between the
F and G fragments, within the VSV L gene (Figures 5A
and 5D). miR93, miR146, and miR378 target the C frag-
ment and are located in the P gene of VSV (Figures 5A
Immunity
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Target VSV
(A) Schematic of the VSV genes. Viral frag-
ments used for constructing luciferase
reporters are as indicated from A to J.
(B) RAW 264.7 macrophages were transiently
transfected with the luciferase reporter con-
structs, and the luciferase activity was mea-
sured. Symbols are used as follows: +, positive
strand reporter; and , negative strand re-
porter. The relative luciferase activities were
calculated by dividing firefly luciferase values
(FL) with internal control renilla luciferase
values (RL). Data are shown as mean ± SD
from three experiments.
(C) Primer-extension analysis shows the
expression of the indicated miRNAs in RAW
264.7 cells and peritoneal macrophages iso-
lated from Dicer1+/+ and Dicer1d/d mice.
(D) Predicted targeting site of miR24, miR93,
miR146, and miR378 in VSV mRNA. The loca-
tions of seed sequences are boxed.
(E) RAW 264.7 macrophages were transfected
with indicated anti-miRNA oligos. Twelve
hours after transfection, the cells were infected
with VSV at m.o.i 10. Thirty-six hours after
infection, the virus yield was determined by
plaque assay. Data are shown as mean ± SD
from duplicate samples of three independent
experiments. *p; = 0.018, and **p = 0.019.
(F) The experiments were performed as
described in (E), except that double-stranded
miRNA precursors were transfected instead
of anti-miRNA oligos. Data are shown as
mean ± SD from three experiments. *p; =
0.042, **p = 0.029, and ***p = 0.018.and 5D). The VSV L and P genes respectively encode the
viral RNA-dependent RNA polymerase and a polymerase
cofactor (Das and Pattnaik, 2004).
To determine whether any of these four miRNAs
suppressed VSV, we used complementary 20-O-methyl
oligonucleotides (oligos) to inhibit selected miRNAs.
Reporter C+ expression was increased by anti-miR93
oligos, was modestly enhanced by anti-miR146 and
anti-378, and was not affected by either an oligo with a
random sequence (control) or anti-miR24 (Figure S5A),
indicating that the reporter C+ expression can be rescued
by sequence-specific inhibition of selected miRNA. The
expression of reporter F+ and G+ were substantially
rescued by anti-miR24, but not the nonrelated anti-
miR378 and control oligos (Figures S5B and S5C), further
supporting the role of miRNA in regulating the expression
of the VSV reporters. To determine whether these miRNAs
interfere with VSV replication, we measured VSV titers af-
ter infection of RAW 264.7 cells that had been transfected
with control, anti-miR24, anti-miR93, anti-miR146, or anti-
miR378 oligos. Consistent with the results of the reporterassay, the virus titer was approximately five and four times
greater in the anti-miR24- and anti-miR93-treated cells,
respectively (Figure 5E), whereas anti-miR146 and anti-
miR378 only had a modest effect on VSV replication in
macrophages (Figure 5E). It should be noted that the
anti-miRNA oligos used here have an approximate 70%
complementary sequence with the negative strand of
VSV. However, this level of complementarity is unlikely
to exert an effective antisense inhibition, and these anti-
miRNA oligos cannot directly interfere with the VSV
genome. This prediction has been validated by reporter
assays (data not shown) and is further supported by the
fact that treatment of cells with these oligos enhanced,
instead of reduced, VSV replication (Figure 5E).
Conversely, we transfected RAW 264.7 cells with
double-stranded miRNA precursors to increase cellular
amounts of miR24, miR93, miR146, or miR378, and we
evaluated the ‘‘overexpression’’ effect of these miRNAs
on VSV. Increasing the amount of miR93, miR146, or
miR378, but not the control sequence or miR24, reduced
luciferase expression from the reporter C+ (Figure S5D).Immunity 27, 123–134, July 2007 ª2007 Elsevier Inc. 129
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Targeting Sites in VSV Abolish Dicer1-
Dependent Suppression of VSV Growth
(A) Schematic of wild-type (WT) and two VSV
mutants. The mutated nucleotides are indi-
cated by arrows. VSV WT is a VSV that was
recovered by transfection of pVSVFL(+) with-
out mutations. VSV M2 is a VSV-containing
mutation in its two possible miRNA target sites
(miRNA24 and miR93). VSV M4 is a VSV-
containing mutation in its four possible miRNA
target sites (miR24, miR93, miR146, and
miR378).
(B and C) Single-cycle growth kinetics of WT,
M2, and M4 VSV were analyzed. Peritoneal
macrophages from Dicer1+/+ and Dicer1d/d
mice were infected with VSV WT, VSV M2,
or VSV M4 at m.o.i. 20, and culture superna-
tants were collected at 4, 8, 12, and 16 hr after
infection. The viruses in the supernatants were
quantitated with the standard plaque assay.
The average values from duplicate samples
of three independent experiments are pre-
sented with error bars showing SD.
(D) Five-week-old male C57BL6 mice were
infected intranasally with 2 3 107 pfu VSV WT
or M2 per mouse (n = 12 in each group). Mice
were monitored daily for 20 days, and animals
surviving at the indicated times are plotted
versus time. *p; = 0.046 (log-rank test).Increased expression of miR24, but not miR378 or the
control, reduced reporter F+ and G+ expression (Figures
S5E and S5F). The results were statistically significant,
but the quantitative effect was small, probably reflecting
the sufficiency of these miRNAs in nontransfected RAW
264.7 cells. As with the reporter assay, increased expres-
sion of miR24, miR93, and miR378 suppressed VSV
multiplication by approximately 50% in comparison with
the control miRNA (Figure 5F), whereas increased expres-
sion of miR146 only had a modest effect on VSV multipli-
cation. Collectively, our data show that some endogenous
miRNAs suppress VSV propagation in macrophages.
To validate that some host miRNAs do indeed inhibit
VSV propagation, we created two VSV mutants that can-
not be targeted by some or all of the four miRNA candi-
dates. One mutant (M2) contains synonymous mutations
within the predicted seed sequences of miR24 and
miR93 (Figure 6A), and the other (M4) has synonymous
mutations in the potential targeting sites of miR24,
miR93, miR146, and miR378 (Figure 6A). Analyses of sin-
gle-cycle growth kinetics showed that M2 and M4 repli-
cate with similar rates, and both grew more quickly and
reached greater final titers than unmodified wild-type
VSV in wild-type macrophages (Figure 6B); these findings
indicate that a cellular-suppression mechanism indeed
occurs through miR24- and miR93-targeting sequences.
Moreover, mutated and wild-type VSV exhibited very
similar growth properties in Dicer1d/d macrophages (Fig-
ure 6C), confirming that cellular miR24 and miR93 are
responsible for the Dicer1-mediated suppression of VSV
replication in wild-type macrophages. We noticed that130 Immunity 27, 123–134, July 2007 ª2007 Elsevier Inc.the growth of our mutated VSV in wild-type macrophages
was still slower than that of mutated and wild-type VSV in
Dicer1d/d cells (Figures 6B and 6C). A possible interpreta-
tion of this phenomenon is that an unidentified miRNA
(or miRNAs) is also involved in the suppression of VSV,
or it could be that some other unknown mechanism is
involved. The role of miR24 and miR93 in anti-VSV
responses was further confirmed by the fact that the
VSV mutant (M2) lacking miR24 and miR93 targeting sites
was more pathogenic than wild-type VSV in wild-type
C57BL/6 mice (Figure 6D). Collectively, our data demon-
strate that the impairment of miR24 and miR93 production
caused by Dicer1 deficiency is the major cause of the
observed increase in susceptibility to VSV in Dicer1d/d
mice.
DISCUSSION
Previous studies have shown that deletion of Dicer1 is
embryonically lethal in mice, and this finding limits the
study of Dicer1 in adult mice. Tissue-specific knockouts
of Dicer1 have allowed the study of Dicer1 function in
selected tissues in adult mice, but the global effect of
Dicer1 deficiency has not yet been addressed. The
Dicer1-deficient mice we generated should serve as a use-
ful tool for analyses of Dicer1’s function in adult mice. By
using this Dicer1-deficient mouse line, we found that
Dicer1d/d mice have increased susceptibility to VSV-
induced lethality. In vitro studies involving Dicer1-deficient
macrophages showed that impairment of Dicer1 affects
the replication of some viruses but not the others,
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is not a general anti-viral mechanism in mammals. How-
ever, because of tissue-specific infection of different
viruses and differential expression of miRNA in different
cell types, the lack of an effect by a given virus in
Dicer1-deficient macrophages does not exclude the
possibility that the same virus can be affected by a Dicer1
deficiency in other cell types or tissues. By studying the
increased susceptibility to VSV in Dicer1d/d cells and
mice, we found that endogenous miRNA can target VSV
and that the defect in miRNA processing is responsible
for the increased susceptibility to VSV infection in
Dicer1d/d mice. Our data provide solid genetic evidence
in supporting the hypothesis that host miRNA can influ-
ence viral growth in mammals
Deficiencies in individual Dicer paralogues in A. thaliana
and Drosophila have been shown to cause increased
susceptibility to RNA virus infections (Voinnet, 2005;
Wang et al., 2006; Galiana-Arnoux et al., 2006), and we
show here that the effect of hypomorphic expression of
murine Dicer1 on viruses varies depending on the type
of virus (Figure 2A). Because viral genome-derived siRNA
produced by Dicer is a major anti-viral mechanism in
plants, C. elegans, and Drosophila (Voinnet, 2005; Wang
et al., 2006; Galiana-Arnoux et al., 2006; Wilkins et al.,
2005; Lu et al., 2005), but no siRNA derived from a viral
genome in mammalian cells has been found, Dicer1’s
role in host defense against viruses might have evolved
differently in mammals compared with these other organ-
isms. A recent paper showed that the suppression of the
miRNA pathway by HIV allows for efficient viral replication
(Triboulet et al., 2007), further supporting the role of mam-
malian miRNA in host defense against some viruses. In
contrast, no study has addressed whether any endoge-
nous miRNA has a role in host defense in invertebrates.
By using VSV mutants generated by a reverse genetics
system, we unambiguously showed that miR24 and
miR93 directly inhibit VSV in mammalian cells.
All known mammalian miR24 and miR93 are conserved,
suggesting that their ability to restrict VSV proliferation
may extend to natural VSV hosts such as cows and sheep.
Although miR24 and miR93 are ubiquitously expressed in
different tissues (Barad et al., 2004), the abundance of
miR24 and miR93 in the epithelial layer of the tongue
and other major VSV replication sites may be important
in determining whether effective host defense against
VSV can occur by miRNA. In addition, cellular activation
by bacterial or viral components can alter some miRNAs’
expression, such as those of miR146 or miR155, and such
alteration could affect viral infection (O’Connell et al.,
2007). Mammals are not likely to encode miRNA capable
of influencing every virus. On the other hand, miRNA-
targeting RNA does not require perfect base pairing, and
in some cases, a single eight-base complement is suffi-
cient to guide RNA degradation or translational suppres-
sion. Therefore, the effect of host miRNAs on viruses
could be widespread.
The exact mechanism leading to the survival of our
Dicer1-deficient mice will require future studies. Becauseof the mixed genetic background of the mice, the possibil-
ity exists that the increased VSV sensitivity in Dicer1d/d
mice is not due to Dicer1 deficiency, but to genetic-back-
ground differences or another mutation. Our analysis of
microsatellite markers showed a similar distribution of
129 and C57BL/6 sequences in wild-type and Dicer1d/d
mice, suggesting that it is unlikely (but not impossible)
that genetic-background differences or a mutation on
a gene other than Dicer1 is responsible for the increased
VSV sensitivity in Dicer1d/d mice. This possibility was ex-
cluded after reviewing additional evidence showing that
VSV variants that cannot be targeted by miR24 and
miR93 are insensitive to Dicer1 in macrophages and are
more pathogenic in wild-type mice. Therefore, Dicer1
deficiency should at least be the main cause of the
increased VSV sensitivity in Dicer1d/d mice and cells.
The targeting of specific viruses by individual miRNAs
could be fortuitous. However, it might reflect a dynamic
evolutionary process in which either the host or the virus
might gain ascendancy. Because host miRNA can target
infected viruses, viruses should be subjected to evolution-
ary pressure to avoid regions of complementarity to miR-
NAs present in their host cells. Some miRNAs might have
been evolutionarily selected to suppress a virus by target-
ing indispensable parts of the viral genome. On the other
hand, viruses such as HCV might have evolved their own
homologies to host miRNAs in order to permit host-
directed processing events. It is plausible that miRNAs
might have an important role in determining the tissue
tropism of viruses and the balance of the ascendancy
between hosts and viruses (Cullen, 2006). Our study
reported here nevertheless supports the notion that
miRNA may represent another layer of the complexity of
virus-host interaction.
EXPERIMENTAL PROCEDURES
Generation of Dicer1d/d Mice
The mouse Dicer1 disrupted 129p2/Ola ES cell clone (RPF266) pro-
duced with a retrovirus vector on the basis of the gene-trap technology
employed at BayGenomics was purchased from the Mutant Mouse
Regional Resource Center (MMRRC, University of California Davis,
Davis, CA). The exact gene-disruption position was determined by
RT-PCR and genomic DNA PCR, with several pairs of primers derived
from the Dicer1 gene and the gene-trap-vector sequences. Dicer1d/d
ES cells were injected into C57BL/6 blastocysts, and chimeric male
mice were bred to C57BL/6 wild-type female mice. The resulting
Dicer1+/d offspring were interbred to produce Dicer1d/d mice and
maintained on a mixed 129/Ola and C57BL/6 background. Genotyping
was carried out by PCR with tail DNA from mice and the following three
primers: sense primer-P1 (mDicer1 intron 24) 50-ccttgcgtggtcagcat
tagcatt-30 for mutant and wild-type alleles, antisense primer-P2
(mDicer1 exon 25) 50-ttctcctcatcctcctcggatctc-30 for wild-type alelles,
and antisenes primer-P3 (retrovirus intron) 50-cactccaacctccg
caaactccta-30 for mutated alleles. All experiments were carried out in
compliance with the rules of the Animal Use Committee of The Scripps
Research Institute.
RT-PCR Analysis
For determining the wild-type Dicer1 mRNA expression, whole
embryos at embryonic day 9.5 were homogenized and total RNA
was extracted. Real-time PCR was performed with the ABI PRISMImmunity 27, 123–134, July 2007 ª2007 Elsevier Inc. 131
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detect only the wild-type Dicer1 mRNA. The relative RNA amount
was calculated with theDDCt method and was normalized with internal
control GAPDH.
Immunoblotting Analysis and Antibodies
The cell extracts and homogenized mouse tissues were normalized for
protein concentration with the Bio-Rad Dc Protein Assay Kit (Bio-Rad,
Hercules, CA). Immunoblots were performed as described (Jing et al.,
2005). Rabbit polyclonal antibodies against Dicer1 were a gift of Dr.
Saigo (Department of Biophysics and Biochemistry, University of
Tokyo, Japan) (Doi et al., 2003). Mouse polyclonal antibodies against
VSV were described previously (Zhang et al., 2004). Rabbit polyclonal
b actin antibodies and mouse GAPDH antibodies were purchased from
Sigma (St. Louis, MO) and Chemicon (Temecula, CA), respectively.
Primer Extension
Primer extension was performed as described previously (Jing et al.,
2005). The primer sequences of miR24, miR93, miR146, and miR378
are 50-ctgttcctgctgaactga-30, 50-ctacctgcacgaacagc-30, 50-aacccatg
gaatttcagtt-30, and 50-acacaggacctggagtca-30, respectively; the
others are in Figure S4.
In Vitro Infection of Viruses
HSV-1 (VR-1493), ECMV (VR-129B), and Influenza A Virus (H1N1)
(strain A/PR/8/34; VR-1469) were obtained from ATCC (Manassas,
VA). LCMV and CVB3 have been described previously (Martinez-
Sobrido et al., 2006). Plaque-purified VSV (Indiana strain) and Vaccinia
virus (vTF7-3) was also described previously (Jiang et al., 2005; Das
and Pattnaik, 2005). Thioglycollate-elicited mouse peritoneal macro-
phages were plated at a density of 105 per well in 96-well plates, and
they were infected with viruses at an m.o.i of 1.0 or infected with influ-
enza virus at 107 TCID50 in serum-free DMEM for 45 min at 37
C. The
inoculum was removed and washed twice with DMEM containing 5%
FBS. Culture supernatants were harvested at 24 hr after infection. Virus
yield was determined by standard plaque assays of serially diluted viral
suspensions on L929 cells (for VSV and EMCV) and BHK cells (for
HSV-1 and vaccinia virus) as described (Jiang et al., 2005). Influenza
virus titers were determined by TCID50 analysis with MDCK cells.
In Vivo Experiments
Sex- and age-matched mice were infected intranasally with 2 3
107 pfu VSV per mouse and monitored daily for 20 days. Lung sections
were stained with hematoxylin and eosin. Immunochemical analysis of
VSV antigens in lung tissues was performed with sheep polyclonal VSV
antibodies provided by Dr. Reiss (Biology Department, New York
University, NY) and DAB peroxidase substrate (Sigma, St. Louis,
MO). For determining the viral titer, the brain was aseptically removed
6 days after infection and homogenized, and a plaque assay was
performed.
Analysis VSV Infection and Replication
For analysis of VSV protein and mRNA synthesis, 1 3 106 peritoneal
macrophages were plated and infected at m.o.i 10 (protein analysis)
or 500 (mRNA analysis) and processed as described previously (Das
and Pattnaik, 2005). For the analysis of virus penetration, cells were
incubated with 0.25% trypsin and 0.025% EDTA for 7 min at room tem-
perature to remove viruses adsorbed to the cell surface after 2 hr of
infection (Belkowski and Sen, 1987) in the presence of cycloheximide
(10 mg/ml, to prevent newly synthesized protein), and the amount of
intracellular VSV proteins was analyzed by immunoblotting. For as-
sessing the cytolytic effect of VSV, cells were stained with crystal violet
at the stated time after infection.
RNA Blotting
Enriched small RNA was extracted with a mirVana RNA Isolation Kit
(Ambion, Austin, TX) according to the manufacturer’s instructions.
Twenty mg of small RNA were separated through a 15% TBE-urea132 Immunity 27, 123–134, July 2007 ª2007 Elsevier Inc.gel and transferred to Hybond-XL membranes (Amersham Pharmacia
Biotech, Buckinghamshire, UK). For miRNA detection, 32P-labeled
Starfire oligo DNA probes complementary to let7a and miR16 (IDT,
Coralville, IA) were used. For the detection of virus-derived small
RNA fragments, the VSV N gene region was used for generating
a 32P-labeled probe with a DECAprime II Random Priming DNA Label-
ing Kit (Ambion).
Ribonuclease Protection Assay
The varying amounts of tumor necrosis factor alpha (TNFa), IFNb, mac-
rophage migration inhibitory factor (MIF), a ribosomal protein (L32),
and glycelaldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in
peritoneal macrophages after VSV infection were analyzed by ribonu-
clease-protection assay (RPA) with the RPA III Kit (Ambion) according
to the manufacturer’s instructions. For identifying the protected bands,
the probe without RNase treatment was also applied. RNA probes
used for this assay were synthesized by in vitro transcription with tem-
plates included in an mCK-3b Mouse Cytokine Multi-Probe Template
Set (PharMingen, San Diego, CA).
Biological Assay of Type 1 IFN
Type I IFN activity was measured with reference to a recombinant
mouse IFN-b standard with an L-929 cell line transfected with an inter-
feron-sensitive luciferase construct as described previously (Jiang
et al., 2005).
Electrophoretic Mobility Shift Assay
The methods for nuclear extraction and electrophoretic mobility shift
assay were described previously (Otsuka et al., 2000). A 32P-labeled
double-stranded oligonucleotide corresponding to the ISRE of the
IFNa/b inducible ISG15 gene (50-GATCGGAAAGGGAAACCGAAACT
GAAGCC-30) was used as a probe.
Semiquantitative RT-PCR of IFN Response Genes
Peritoneal macrophages extracted from wild-type and Dicer1d/d mice
were infected with VSV at an m.o.i of 0.1. RNA was extracted at the
indicated time points after infection, and semiquantitative RT-PCR
was performed as described (Ono et al., 2001).
Reporter Plasmids and Reporter Assay
The plasmid pVSVFL(+) expressing 11,161-nucleotide positive-strand
(antigenomic) VSV RNA sequence was kindly provided by Dr. Whitt
(Department of Molecular Sciences, University of Tennessee Health
Science Center, TN) (Lawson et al., 1995b). We constructed the
reporter plasmids by subcloning PCR-amplified DNA fragments from
the pVSVFL(+) into the 30 UTR region of a Photinus pyralis (firefly) lucif-
erase reporter gene. For checking the transfection efficiency, pRL-TK,
a control plasmid (Promega, Madison, WI), was used. Transfection
was performed with Lipofectamine 2000 (Invitrogen). Luciferase as-
says were carried out with the Dual-Luciferase Reporter Assay System
(Promega).
Prediction of miRNA Target Sites in VSV RNA
Two computational microRNA-target-prediction programs, MicroIns-
pector (Rusinov et al., 2005) and DIANA-microT (Kiriakidou et al.,
2004), were used to predict miRNA-binding sites in VSV RNA se-
quences. MicroInspector was run with the hybridization temperature
set to 37C and the free-energy cutoff set to 22 kcal/mol. Among
primary candidate microRNA sequences, those that showed the
symmetry of binding were selected by the inspection of the individual
binding structures according to the authors’ recommendation. DIANA-
microT was run with the free-energy cutoff set at 22 kcal/mol.
Inhibition and Overexpression of miRNA
Anti-miRNA24, 93, 146, and 378 oligonucleotides (oligos), as well as
a random sequence anti-miRNA oligos, were purchased from Ambion.
For reporter assays, 0.5 mg of reporter plasmids and 100 nM anti-
miRNA oligos were cotransfected into RAW 264.7 cells. A luciferase
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50 nM anti-miRNA oligos were transfected into RAW 264.7 cells.
Twelve hours after transfection, the cells were infected with VSV at
m.o.i 10. Thirty-six hours after infection, the virus yield was determined
by the plaque assay. Double-stranded miRNA24, 93, 146, and 378
precursors and a random sequence miRNA precursor were also ob-
tained from Ambion. Reporter assays and viral-titration assays were
performed as the anti-miRNA oligo experiments, except the miRNA
precursor concentration was 30 nM.
Generation of Mutant VSV Viruses
The plasmids pN, pP, and pL carrying the coding sequences of N, P,
and L proteins of VSV under the control of T7 RNA polymerase
promoter have been described previously (Lawson et al., 1995a). For
constructing the plasmid pVSVFL(+) with a mutation in the miRNA24
target site, pL with the same mutation was generated with the Quik-
Change XL site-directed mutagenesis kit (Stratagene) and cut with
SalI and HpaI, and the fragment was inserted into pVSVFL(+) digested
at those sites. For constructing the plasmids with mutations in the pos-
sible miRNA93, 146, and 378 target sites, the fragment containing P
gene region was excised with EcoRV from pVSVFL(+) and cloned
into pBluescriptII at those sites, then site-directed mutagenesis was
performed. The fragments with designed mutations were digested
with EcoRV, and cloned into pVSVFL(+) with mutation in the miRNA24
target site at the same sites. All cones were sequenced to confirm the
presence of the mutations. Transfection, recovery of mutant viruses,
plaque purification, and confirmation of desired mutations in the
viruses were performed by previously described methods (Das and
Pattnaik, 2005).
Determination of Single-Step Growth Kinetics of VSV
Peritoneal macrophages were plated at a density of 106 cells per well in
48-well plates. Cells were infected with either wild or mutant viruses at
an m.o.i of 20. After adsorption for 45 min, the cells were washed twice,
and 250 ml of fresh medium was added. Aliquots of 20 ml of culture
supernatant were collected at various times after infection. The
amount of virus present in the supernatant was determined by plaque
assay.
Microsatellite-Markers Analysis
Microsatellite loci were amplified by PCR with fluorescently labeled
forward and unlabeled reverse primers. The PCR amplicons were
separated by size with electrophoresis, and the dye-labeled products
were identified by fluorescence detection; all of these procedures were
done by ABI 3130 Automated Capillary DNA Sequencer. The allele
information is then analyzed by GeneMapperR V3.7 (ABI).
Statistical Analysis
Kaplan-Meier plots were constructed, and a log-rank test was used to
test for differences in survival between Dicer1+/+ and Dicer1d/d mice
after viral infection. The statistical significance of any differences in
in vitro experiments was determined with the Student’s t test or the
Welch’s t test when variances were unequal.
Supplemental Data
Five figures and one table are available at http://www.immunity.com/
cgi/content/full/27/1/123/DC1/.
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